The retinoblastoma gene product pRb and other members of the Rb family of pocket proteins have a central role in the regulation of cell cycle progression. Soon after its discovery, pRb was found to interact with the transforming oncoproteins of DNA tumor viruses and this led to rapid advances in our understanding of the mechanisms of viral transformation and cell cycle progression. DNA viruses of the polyomavirus family have small, circular, double-stranded DNA genomes contained within nonenveloped icosahedral capsids and are highly tumorigenic in experimental animals. At least three types of polyomavirus infect humans: JC virus (JCV), BK virus (BKV) and Simian Vacuolating virus-40. The early region of these viruses encodes the transforming proteins large T-antigen and small t-antigen, which are involved in viral replication and also promote transformation of cells in culture and oncogenesis in vivo. Binding of T-antigen to pRb promotes the activation of the E2F family of transcription factors, which induce the expression of cellular genes required for S phase. In the context of lytic infection, this cell cycle progression is necessary for viral replication because polyomaviruses rely on S phasespecific host factors for their DNA synthesis. In the context of cellular transformation and tumorigenesis, T-antigen/pRB interaction is an indispensable event.
Introduction
Unlike RNA tumor viruses, DNA tumor viruses encode potent oncoproteins that have no cellular homologues. Understanding the interactions of these oncoproteins with cellular regulators helped lay the foundations of our current knowledge of cell transformation, cell cycle regulation and signal transduction. Early milestones include the discoveries of the interaction between SV40 large T-antigen and p53 (Lane and Crawford, 1979) , complex formation between the mouse polyomavirus middle T-antigen and the cellular pp60 cÀsrc protooncoprotein (Courtneidge and Smith, 1983) , and the identification of a cellular protein that binds to the adenovirus E1A protein as being the retinoblastoma gene product (Whyte et al., 1988a) . Retinoblastoma is a childhood tumor of the eye for which it has long been known that there is a hereditary predisposition. The gene for this predisposition (RB) is the prototypical example of a tumor suppressor gene and resides at the q14 band of chromosome 14. In the late 1980s, cDNA encoding the protein product of the RB gene (pRb) was isolated and sequenced (Friend et al., 1986 (Friend et al., , 1987 Fung et al., 1987; Lee et al., 1987a) . The cDNA sequence indicated that pRb was a protein of 928 amino acids that was identified as a nuclear phosphoprotein of 105-110 K (Lee et al., 1987b) . Meanwhile, research on the E1A-transforming protein of adenovirus had identified a set of cellular proteins with which it is found associated in infected cells including one with a similar molecular weight to pRb called p105 (Yee and Branton, 1985; Harlow et al., 1986) . Subsequently, immunoprecipitation experiments with antibodies to p105 protein and antibodies to the predicted pRb sequence, together with protease mapping, demonstrated that pRb and p105 are identical. The importance of this association was indicated by deletion mapping experiments that demonstrated that the regions of E1A that are required for interaction with pRb coincided precisely with the regions of E1A that are required for its transforming function (Whyte et al., 1988b . Similarly co-immunoprecipitation studies showed that the large T-antigen of SV40 also forms a complex with pRb. Mutants of T-antigen that contained structural alterations in a 10 residue, transformation-controlling domain (LXCXE domain) failed to complex with pRb indicating that transformation by SV40, at least in part, involves perturbation of the pRb protein (DeCaprio et al., 1988) . SV40 large T-antigen binds preferentially to the lower molecular weight hypophosphorylated of pRb . Co-immunoprecipitation assays demonstrated that the large T-antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein . These included the large T-antigens of mouse, monkey, baboon or human polyomaviruses. Owing to these early experiments, much has been learned about the nature and the functional significance of this interaction in the polyomavirus life cycle during lytic infection and during cellular transformation by large T-antigen in a non-lytic setting. In this review, we examine these advances with special emphasis on the polyomaviruses that have been found to be able to infect humans, that is, JC virus (JCV), BK virus (BKV) and Simian Vacuolating virus-40 (SV40).
Human polyomaviruses
Polyomaviruses are DNA tumor viruses with small circular genomes that have been found to cause disease in a variety of species of animals including humans (Cole, 1996) . These viruses belong to the taxonomic family Polyomavirinae that exhibit a very limited host range with regard to the host species that they are able to infect (Cole, 1996) . Three polyomaviruses have been described in humans: JCV, BKV and SV40. All three viruses transform cells in culture and are highly oncogenic in experimental animals and may be associated with some clinical tumors (reviewed in White and Khalili, 2004a; . JCV is a neurotropic polyomavirus, that is the proven etiologic agent of progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system occurring in immunocompromised individuals, mainly AIDS patients . BKV is the causative agent of polyomavirus-associated nephropathy (PVN) that occurs after renal transplantation when BKV reactivates from a latent state during the course of immunosuppressive therapy to cause damage to the allograft tissue and this can lead to complete failure of the transplanted organ in some patients (Hirsch, 2005) . SV40 is a polyomavirus of rhesus macaque origin that was discovered as a contaminant in early batches of polio vaccine. The prevalence of SV40 infections in humans today is not known (Garcea and Imperiale, 2003) . These three polyomaviruses are very closely related to each other phylogenetically with respect to size (approximately 5200 bp), genome organization and nucleotide sequence. The circular genome of these viruses contains two coding regions, the early and late transcription units that are regulated by a common noncoding control region that contains the start sites for transcription, binding sites for the transcription factors and the origin of DNA replication (Figure 1 ). The late region encodes the structural capsid proteins VP1, VP2 and VP3 and a small regulatory protein known as agnoprotein. The early region encodes the alternatively spliced transforming proteins large T-antigen and small t-antigen. These proteins have long been known to be important in promoting transformation of cells in culture and highly efficient oncogenesis in vivo when virus is inoculated into animals or when the early region is introduced into transgenic mice. In the case of JCV, three additional splice variants of T-antigen (T (Trowbridge and Frisque, 1995) that may also have important functions including differential regulation of pRb and other members of the retinoblastoma family of proteins (Bollag et al., 2000; Frisque, 2001; Prins and Frisque, 2001; Frisque et al., 2003 Frisque et al., , 2005 Tyagarajan and Frisque, 2005) .
In the host species, polyomaviruses spread by lytic infection of permissive cells. However, in non-permissive cells, infection is abortive and cellular transformation may occur. The phenotypic features of cellular transformation in cell culture, the production of tumors in experimental animals and the association of polyomaviruses with clinical tumors have been reviewed recently (White and Khalili, 2004a; . Transformation requires expression of the early region, in particular the large T-antigen. Large T-antigen is a large nuclear phosphoprotein essential for viral DNA replication. Large T-antigen binds to the viral origin of DNA replication where it promotes DNA synthesis (Cole, 1996) . Polyomaviruses rely on cellular enzymes and cofactors for DNA replication as the genome of polyomaviruses does not encode replication proteins. Expression of the cellular proteins that are involved in DNA replication is confined to the S phase of the cell cycle. For this reason, large T-antigen modulates cellular signaling pathways, including ones that are regulated by pRb, to stimulate progression of the cell cycle. Large T-antigen interacts with a plethora of cellular proteins that promote cell cycle progression into S phase and a corollary of this is that it is a major factor (Trowbridge and Frisque, 1995) , Agno -the late auxiliary protein, agnoprotein, ELP -putative early leader protein.
pRb and T-antigen MK White and K Khalili in the transformation of virus-infected cells. Perhaps the most well-known of these interactions in this respect are the ability of T-antigen to associate with, and interfere with the functions of, the two tumor suppressor proteins, pRb and p53. However, the functions of many other cellular proteins have been shown to be dysregulated through interaction with large T-antigen and these have been reviewed recently Khalili, 2004b, 2005) . In this review, we will focus on the interaction of large T-antigen with retinoblastoma protein family members.
The retinoblastoma family of proteins
As discussed in the Introduction, soon after its discovery in the mid-1980s, the retinoblastoma gene product, pRb, was found to bind to the transforming proteins of DNA tumor viruses. This provided one of the first paradigms of the interaction between the gene products of oncogenes and anti-oncogenes. In 1991, this paradigm was extended by the discovery that the transcription factor E2F could be bound and sequestered by the hypophosphorylated form of pRb and that E2F could be displaced by large T-antigen or E1A Chellappan et al., 1991; Chittenden et al., 1991; Nevins et al., 1991; Raychaudhuri et al., 1991) . E2F was first discovered as a factor that promoted transcription of the adenovirus E2F promoter, the activity of which is induced by the adenovirus E1A protein Reichel et al., 1987) . Since this discovery, there have been rapid advances in the field and it is now known that there are at least eight proteins in the E2F family (E2F-1 to E2F-8) that includes both transcriptional activators and repressors that control many hundreds of cellular genes that are involved not only in control of cell cycle progression and DNA replication but also DNA repair, differentiation and apoptosis. Several excellent recent reviews are available on this subject (Attwooll et al., 2004; Blais and Dynlacht, 2004; Bracken et al., 2004; Dimova and Dyson, 2005) . In addition, the pRb protein has additional family members. Molecular cloning of the p107 cellular protein that forms specific complexes with E1A and large T-antigen revealed that it possessed significant homology to pRb (Ewen et al., 1991) . Similarly, the p130 cellular protein, which binds to viral oncoproteins, has been cloned and is also sometimes referred to as pRb2 (Hannon et al., 1993; Li et al., 1993; Mayol et al., 1993 ; see also Genovese et al., in this issue).
pRb and the related pocket proteins restrain G1 to S progression though the regulation of E2F-responsive genes. pRb and p107/p130 regulate distinct sets of genes by selective interactions with different E2F family members, for example, pRb preferentially binds E2F-1, E2F-2, E2F-3a and E2F-3b whereas p107 and p130 preferentially bind E2F-4 and E2F-5. Many key aspects of the central role of pRb in the normal progression of the cell cycle were understood by the early 1990s (Weinberg, 1995 (Weinberg, , 1996 . pRb is maintained in a hypophosphorylated form during G0 but becomes increasingly phosphorylated during the G1 progression resulting from the action of mitogenic signals through cyclin-dependent kinases and this leads to the activation of E2F transcriptional activity. The details of these processes have been reviewed recently (Cobrinik, 2005) . We will now consider the pathological effects of the large T-antigen of the three different human polyomaviruses on the function of pRb and its family members.
Interaction of SV40 large T-antigen with pRb and its family members
As discussed in the Introduction, the discovery of the interaction of the newly discovered retinoblastoma gene product, pRb, with oncoproteins of DNA tumor proteins in the 1980s preceded the elucidation of the role of pocket proteins as key regulators of cell cycle progression. Co-immunoprecipitation studies in monkey cells expressing SV40 large T-antigen demonstrated that it forms a complex with pRb (DeCaprio et al., 1988) . T-antigen mutants that contained structural alterations in a 10 residue, transformation-controlling domain (LXCXE domain) failed to complex with pRb indicating that transformation by SV40, at least in part, involves perturbation of the pRb protein. Whereas antibodies to pRb immunoprecipitated proteins in the range 110-114 kDa, only p110 co-immunoprecipitated with antibody to SV40 large T-antigen showing that it binds preferentially to the lower molecular weight hypophosphorylated form of pRb . The same amino-acid sequence element (LXCXE domain) of the large T-antigen protein also contributed to the formation of a complex with a second cellular protein with an apparent molecular of 120 kDa (Ewen et al., 1989) . Presumably this second protein is pRb2 (see below). [
35 S]-Methionine pulse chase experiments with synchronized cells showed that pRb becomes phosphorylated at the start of S phase and dissociates from T-antigen until the end of G2 when pRb undergoes dephosphorylation and again complexes with T-antigen (Ludlow et al., 1990) . The binding of pRb to large T-antigen is not required for the replication of SV40 as the ability of T-antigen to mediate transcriptional activation of viral genes and viral DNA replication occurs efficiently in cells that express pRb and in cells that lack pRb (Trifillis et al., 1990) . Two non-contiguous regions of the pRb protein are essential for complex formation with adenovirus E1A and SV40 large T-antigen proteins, and these two binding sites overlap with the positions of naturally occurring mutations that inactivate the RB gene (Hu et al., 1990; Huang et al., 1990) .
Wild-type and mutant forms of SV40 large T-antigen have been used to dissect the role of pRb in transgenic mice. A mutant T-antigen comprising only the N-terminal 141 amino acids retains the ability to interact with pRb but not p53. This mutant retained the ability to induce choroid plexus tumors that were histologically similar to those induced by wild-type T-antigen but developed more slowly. In contrast, mutation of a residue in the pRb-binding domain abolished the ability of large T-antigen to induce such tumors (Saenz Robles et al., 1994) . SV40 large T-antigen also binds to other members of the pRb family of proteins. Before it was cloned, it was recognized that the cellular p107 protein that binds to the adenovirus E1A protein also associates with the large T-antigens of SV40 and JCV (Dyson et al., 1989) . Interaction involves the same 10 amino-acid LXCXE domain that is involved in pRb binding. Similarly, the p130 cellular protein, pRb2 binds to large T-antigen (Hannon et al., 1993; Li et al., 1993; Mayol et al., 1993) . Mutations in the 10 amino-acid LXCXE domain abrogate p107 and pRb2/p130 binding as well as pRb. An indication of the importance of p107 and pRb2/p130 binding to the 10 amino-acid domain comes from the observation that it is still required for the transformation of Rb-negative mouse fibroblasts (Christensen and Imperiale, 1995) . During the transformation of NIH3T3-L1 cells by SV40 large T-antigen, it was found that T-antigen bound to the pocket region of pRb2/p130 disrupted its association with E2F (Wolf et al., 1995) . In pRb knockout mice fibroblasts, Zalvide and Decaprio (1995) reported that wild-type SV40 large T-antigen conferred a growth advantage over mutants in the pRb-binding motif. Wild-type, but not mutant, large T-antigen could bind to p107 and pRb2/p130 and disrupt p107-E2F and pRb2-E2F complexes in these cells. In cells expressing T-antigen, it was also found that p107 and pRb2/p130 were hypophosphorylated (Stubdal et al., 1996) . Discrete separable subpopulations of SV40 T-antigen bound to cellular proteins have been identified by a sequential immunoprecipitation approach. These include a quatramolecular complex with pRb, p107 and p53, a trimolecular complex with pRb and p107, and a trimolecular complex with p107 and p53 (Ludlow, 1996) .
As discussed above, a 10-residue, transformationcontrolling domain of T-antigen is involved in complex formation with pRB and the other pocket proteins that is also known as the LXCXE domain. The N-terminal region of T-antigen is also required for this interaction and this region is known as the J-domain because of its homology to DnaJ and it confers a molecular chaperone function to T-antigen (see Sullivan and Pipas (2002) for an excellent review). Reintroducing a LXCXE domain to an N-terminally truncated T-antigen confers on cells the ability to grow to high density (Tevethia et al., 1997) . Mutation studies demonstrated that T-antigen-mediated degradation of pRb2/p130 requires the T-antigen J domain as does the effect of T-antigen on p107 and pRb2/p130 phosphorylation (Stubdal et al., 1997) . Furthermore, the J domain is required to override the repression of E2F activity mediated by pRb and pRb2/ p130 implying that whereas the LXCXE domain serves as a binding site for the pocket proteins, the J domain is involved in disrupting their function (Zalvide et al., 1998) . Further studies revealed that SV40 T-antigen dissociates from a complex with p130-E2F-4-DP1 coincident with the release of p130 from E2F-4-DP1.
This dissociation requires Hsc70, ATP and a functional J domain (Sullivan et al., 2000a) . The mechanism of T-antigen J-domain-mediated inhibition of pRb2/p130 phosphorylation has also been investigated. Incubation of pRb2/p130 in a cell-free system prepared from S phase cells results in its phosphorylation. Addition of T-antigen reduces this phosphorylation and this is dependent on an intact J domain and can be inhibited by okadaic acid. This suggests that the T-antigen J domain recruits a phosphatase that acts on pRb2/ p130 (Lin and DeCaprio, 2003) .
X-ray crystallography of SV40 large T-antigen bound to the pocket domain of pRb has revealed the structural basis for the inactivation of pRb by T-antigen. A four helix bundle of large T-antigen together with residues from helices a2 and a4 and from a loop containing the LXCXE motif interact with pRb (Kim et al., 2001 ).
In conclusion, there have been many studies that have delineated the interactions of SV40 large T-antigen with the retinoblastoma family of proteins and how these function in the process of cellular transformation. Interestingly, the situation may be somewhat different in the context of lytic infection by SV40. In the natural host species for SV40, the Rhesus Macaque, the virus spreads as a persistent asymptomatic infection of kidney cells. Surprisingly, in cultured monkey kidney epithelial cells, it has been shown that SV40 infection perturbs p130-E2F and p107-E2F but not pRb-E2F complexes (Sullivan et al., 2004) .
Interaction of BK virus large T-antigen with pRb and its family members
Inactivation of pRb by T-antigen appears to be a common feature of DNA tumor viruses as co-immunoprecipitation assays have demonstrated that the large T-antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein . These included the large T-antigens of mouse, monkey, baboon polyomaviruses, JCV and two different strains of BKV (Dunlop and MM). BK virus, or viral BKV DNA comprising the complete BKV genome or fragments that include the early region are able to transform embryonic fibroblasts and cells cultured from the kidney or brain of mouse, rat, hamster, rabbit and monkey (Corallini et al., 2001; Tognon et al., 2003) . The efficiency of transformation is variable and dependent upon genetic features of the viral strain that is used. The efficiency of BKV T-antigen-induced transformation of hamster cells was improved by the cointroduction of the human c-Harvey-ras oncogene (Pagnani et al., 1988) . In the case of human cells, transformation of human embryonic kidney (HEK) cells by BKV is not efficient and often abortive. Features of the transformed phenotype are not fully displayed. However, a fully transformed phenotype can be achieved in co-operation with other oncogenes such as adenovirus E1A, c-rasA or c-myc (Corallini et al., 2001) .
Like SV40 and JCV, BKV large T-antigen also possesses a J domain and a LXCXE motif site (Pipas, 1992) , and the J domain has molecular chaperone activity in an Escherichia. coli DNAJ replacement assay (Kelley and Georgopoulos, 1997) . BK virus large T-antigen has been shown to have the ability to bind to members of the pRb family both in vivo and in vitro Harris et al., 1996) . However, these interactions are limited owing to the low levels of BKV large T-antigen expression from the viral promoter, which are not sufficient to bind a significant amount of the pRb family proteins in the cell (Harris et al., 1996) . Nevertheless, enough T-antigen is produced to alter the phosphorylation patterns of these proteins and to induce serum-independent growth of cells (Harris et al., 1996) . In these experiments, it was found that, if the amount of BKV T-antigen was increased to the level of the SV40 positive control (by increasing the amount of protein used for the T-antigen immunoprecipitation), BKV T-antigen/pRb complexes were readily detectable as were complexes with p107 and pRb2/p130 (Harris et al., 1996) . Further studies on BKV T-antigen showed that it is able to induce transcriptionally active E2F and that induction requires an intact pRb-binding domain as well as an intact J domain (Harris et al., 1998) . Recently, the full genomic DNA sequence of a fourth primate polyomavirus was published, Simian Agent 12 (SA12) and this revealed that it is most closely related to BKV. The natural host of this virus is thought to be the chacma baboon. The T-antigen of the virus has a conserved J domain and LXCXE pRb-binding motif (Cantalupo et al., 2005) .
Interaction of JC virus large T-antigen with pRb and its family members Dyson et al. (1990) first reported that the characteristic subset of pRb polypeptides co-precipitated with T-antigen-specific antibody from HJC hamster cells expressing JCV large T-antigen. Dyson et al. (1989) also reported the interaction of the p107 protein with JCV large T-antigen. Like SV40, BKV and SA12, JCV large T-antigen also possesses a J domain and a LXCXE motif site (Pipas, 1992) . The J domain has molecular chaperone activity in an E. coli DNAJ replacement assay (Kelley and Georgopoulos, 1997) . JC virus is able to transform cells in culture, particularly cells of glial origin including human fetal glial cells and primary hamster brain cells. JC virus-transformed cells exhibit the phenotypic properties associated with transformation including growth in soft agar, serum-independence, changes in morphology, plasminogen activator production, etc. (reviewed in Del Valle et al., 2001b) . The transforming ability of JCV appears to be limited to cells of glial origin and cell-type-specific transcriptional regulation of the viral promoter is thought to be responsible for this property. Human fetal glial cells have been transformed with an origin-defective mutant of JC to produce a cell line (POJ) that grows continuously in culture and constitutively expresses JCV T-antigen (Mandl et al., 1987) . In domain swapping experiments utilizing the large T-antigen coding regions of JCV and SV40, it was found that the conversion of the JCV T-antigen to that of SV40 did not alter JCV's limited transforming activity (Tavis et al., 1994) . Domain swapping experiments also showed that, whereas JCV T-antigen does not immortalize human fibroblasts and SV40 T-antigen does (with a frequency of about 10%), JCV T-antigen in which the pRb-binding domain was replaced with that of SV40 still failed to immortalize cells but could still cause cellular transformation (O'Neill et al., 1995) . Experiments to investigate the function of the N-terminal J domain have also utilized a domain swapping approach. In chimeras where the SV40 T-antigen was replaced, the J domain of JCV large T-antigen, but not the J domain of yeast Ydj1P or E. coli DnaJ, was able to abolish pRb2/p130-E2F DNA-binding complex (Sullivan et al., 2000b) . This suggests that the J domain of the JCV large T-antigen functions in a similar manner to that of SV40 (discussed above) in large T-antigen-pocket protein interactions. A comparison of JCV large T-antigen with SV40 T-antigen is shown in Figure 2 .
The role of the interaction of pRb in JCV T-antigeninduced tumorigenesis has been investigated in a transgenic mouse model (Krynska et al., 1997) . Transgenic mice harboring the JCV early genome develop tumors of neural crest origin which express high levels of JCV large T-antigen. pRb was found in the phosphorylated state in tumor cell extracts and was detected in association with T-antigen. E2F-1 was also highly expressed in these cells as was proliferating cell nuclear antigen, which is an E2F-1-inducible gene. In another series of experiments with JCV T-antigen-transformed tumor cells, it was shown that introduction of tetracycline-regulated pRb2/p130 into JCV-induced hamster brain tumor cells overcomes cellular transformation and reduces tumorigenicity in nude mice (Howard et al., 1998) . In these experiments, it was found that T-antigen bound to hypophosphorylated pRb2/p130. Further studies revealed the importance of p27 Kip1 and cyclin E in this regulation (Howard et al., 2000) . Krynska et al. (2000) developed a mouse model of human medulloblastoma using the JCV early region and were able to clone two types of tumor-derived cell lines that were either positive or negative for T-antigen expression. In the T-antigen-producing cells, T-antigen was found in association with p53 and pRb. JC virus T-antigen expression can be found associated with some cases of human medulloblastoma (reviewed in . In an immunohistochemical examination of eight medulloblastomas, Del Valle et al. (2001a) detected T-antigen in three of the tumor samples. Nuclear labeling for pRb was detected for five of the cases and was highest in the three samples that were positive for T-antigen. p107 and pRb2 were also immunopositive in most T-antigen-positive medulloblastomas (Figure 3) .
Three additional splice variants of T-antigen (T (Trowbridge and Frisque, 1995) and all contain the J domain and LXCXE motif indicating that they may also have important functions including differential regulation of pRb (Frisque, 2001; Frisque et al., 2003 Frisque et al., , 2005 . Bollag et al. (2000) investigated the interactions of each of baculovirus-expressed and purified JCV T-antigen and the T 0 proteins with pRb family member proteins. All four preferentially bound to the hypophosphorylated form of each protein and exhibited the highest affinity for p107 and the lowest for pRb. T-antigen and T 
Summary
The discovery of the gene product of the retinoblastoma gene product, pRb, and that it interacts with the transforming gene products of the oncogenes carried by many DNA tumor viruses was a seminal observation that opened new fields of investigation into both the regulation of normal cellular proliferation and the mechanisms of viral tumorigenesis. Polyomaviruses are an important pathological agent in the human population especially for AIDS patients suffering from the fatal (Frisque and White, 1992) . The inset shows a schematic of the arrangement of the domains (reproduced with permission, Ludlow, 1993) . JCV-mediated demyelinating disease, PML, and kidney transplant recipients afflicted with BKV-associated nephropathy. In addition, some human tumors may be associated with the expression of the large T-antigen. The interaction of T-antigen with pRb and its family members is a key event in the viral life cycle and may be a target for therapeutic interventions for these diseases.
